Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 2983Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1An Institutional Review Board-Based Clinical Research Quality Assurance Program
Pramod M. Lad,Rebecca Dahl
Accountability in Research.2013;20(1)13
[DOI]
2An Institutional Review Board-Based Clinical Research Quality Assurance Program
Nicole E. Lopez,Lawrence T. Kim
Accountability in Research.2017;20(1)221
[DOI]
3Assessing data quality and the variability of source data verification auditing methods in clinical research settings
Lauren Houston,Yasmine Probst,Allison Martin
Journal of Biomedical Informatics.2018;83(1)25
[DOI]
4Efficacy and safety of laxatives for chronic constipation in long-term care settings: A systematic review
N. Alsalimy,L. Madi,A. Awaisu
Journal of Clinical Pharmacy and Therapeutics.2018;43(5)595
[DOI]
5Efficacy and safety of laxatives for chronic constipation in long-term care settings: A systematic review
Bram Ramjiawan,Angela Ramjiawan,Lorie Forbes,Paramjit S. Tappia
Journal of Clinical Pharmacy and Therapeutics.2013;43(5)177
[DOI]
6Partnerships and Collaborations: The Right Alliances for Clinical Trials in Africa
Olusola Solarin,Sulma I. Mohammed,Ntokozo Ndlovu,Verna Vanderpuye,Victoria Olaiya
JCO Global Oncology.2020;43(6)954
[DOI]
7Are non-constant rates and non-proportional treatment effects accounted for in the design and analysis of randomised controlled trials? A review of current practice
Kim Jachno,Stephane Heritier,Rory Wolfe
BMC Medical Research Methodology.2019;19(1)954
[DOI]
8Are non-constant rates and non-proportional treatment effects accounted for in the design and analysis of randomised controlled trials? A review of current practice
Grant D. Huang,Domenic J. Reda
BMC Medical Research Methodology.2017;19(1)459
[DOI]
9Towards the development of a comprehensive framework: Qualitative systematic survey of definitions of clinical research quality
Belinda von Niederhäusern,Stefan Schandelmaier,Marie Mi Bonde,Nicole Brunner,Lars G. Hemkens,Marielle Rutquist,Neera Bhatnagar,Gordon H. Guyatt,Christiane Pauli-Magnus,Matthias Briel,Roberta W. Scherer
PLOS ONE.2017;12(7)e0180635
[DOI]
10Towards the development of a comprehensive framework: Qualitative systematic survey of definitions of clinical research quality
Vandana Soni,Priyanka Jain,Tanweer Haider,Vikas Pandey,Rakesh K. Tekade
PLOS ONE.2018;12(7)403
[DOI]
11Data Validation and Verification Using Blockchain in a Clinical Trial for Breast Cancer: Regulatory Sandbox
Tomonobu Hirano,Tomomitsu Motohashi,Kosuke Okumura,Kentaro Takajo,Taiyo Kuroki,Daisuke Ichikawa,Yutaka Matsuoka,Eisuke Ochi,Taro Ueno
Journal of Medical Internet Research.2020;22(6)e18938
[DOI]
12‘Screening audit’ as a quality assurance tool in good clinical practice compliant research environments
Sinyoung Park,Chung Mo Nam,Sejung Park,Yang Hee Noh,Cho Rong Ahn,Wan Sun Yu,Bo Kyung Kim,Seung Min Kim,Jin Seok Kim,Sun Young Rha
BMC Medical Ethics.2018;19(1)e18938
[DOI]
13Prototype of running clinical trials in an untrustworthy environment using blockchain
Daniel R. Wong,Sanchita Bhattacharya,Atul J. Butte
Nature Communications.2019;10(1)e18938
[DOI]
14Validation of an automated system for aliquoting of HIV-1 Env-pseudotyped virus stocks
Anke Schultz,Anja Germann,Martina Fuss,Marcella Sarzotti-Kelsoe,Daniel A. Ozaki,David C. Montefiori,Heiko Zimmermann,Hagen von Briesen,Yuntao Wu
PLOS ONE.2018;13(1)e0190669
[DOI]
15A scoping review provided a framework for new ways of doing research through mobilizing collective intelligence
Van Thu Nguyen,Mehdi Benchoufi,Bridget Young,Lina Ghosn,Philippe Ravaud,Isabelle Boutron
Journal of Clinical Epidemiology.2019;110(1)1
[DOI]
16A scoping review provided a framework for new ways of doing research through mobilizing collective intelligence
Stephen Aylward,Lubomir M. Hadjiiski,Thomas M. Deserno,István Sárándi,Abin Jose,Daniel Haak,Stephan Jonas,Paula Specht,Vincent Brandenburg
Journal of Clinical Epidemiology.2014;9035(1)90353C
[DOI]
17A comparative study to evaluate quality of data documentation between investigator-initiated and pharmaceutical industry-sponsored studies
BrinalH Figer,KeyurP Sapra,NithyaJ Gogtay,UrmilaM Thatte
Perspectives in Clinical Research.2020;11(1)13
[DOI]
18A comparative study to evaluate quality of data documentation between investigator-initiated and pharmaceutical industry-sponsored studies
Olivia Choudhury,Issa Sylla,Noor Fairoza,Amar Das
Perspectives in Clinical Research.2019;11(1)1
[DOI]
19Overcoming challenges to data quality in the ASPREE clinical trial
Jessica E. Lockery,Taya A. Collyer,Christopher M. Reid,Michael E. Ernst,David Gilbertson,Nino Hay,Brenda Kirpach,John J. McNeil,Mark R. Nelson,Suzanne G. Orchard,Kunnapoj Pruksawongsin,Raj C. Shah,Rory Wolfe,Robyn L. Woods
Trials.2019;20(1)1
[DOI]
20Creating a “Good Clinical Practices Inspection” Authentic Online Learning Environment through Educational Design Research
Ümit Kartoglu,Ria Christine Siagian,Thomas C. Reeves
TechTrends.2020;64(4)616
[DOI]
21OARSI Clinical Trials Recommendations: Knee imaging in clinical trials in osteoarthritis
D.J. Hunter,R.D. Altman,F. Cicuttini,M.D. Crema,J. Duryea,F. Eckstein,A. Guermazi,R. Kijowski,T.M. Link,J. Martel-Pelletier,C.G. Miller,T.J. Mosher,R.E. Ochoa-Albíztegui,J.-P. Pelletier,C. Peterfy,J.-P. Raynauld,F.W. Roemer,S.M. Totterman,G.E. Gold
Osteoarthritis and Cartilage.2015;23(5)698
[DOI]
22Secure and Scalable mHealth Data Management Using Blockchain Combined With Client Hashchain: System Design and Validation
Tomomitsu Motohashi,Tomonobu Hirano,Kosuke Okumura,Makiko Kashiyama,Daisuke Ichikawa,Taro Ueno
Journal of Medical Internet Research.2019;21(5)e13385
[DOI]
23The Worldwide Environment of Cardiovascular Disease: Prevalence, Diagnosis, Therapy, and Policy Issues
Lawrence J. Laslett,Peter Alagona,Bernard A. Clark,Joseph P. Drozda,Frances Saldivar,Sean R. Wilson,Chris Poe,Menolly Hart
Journal of the American College of Cardiology.2012;60(25)S1
[DOI]
24A Missing Piece in Clinical Trial Inspections in Latin America: Interviews With Research Subjects in Peru
Gabriela E. Minaya,Duilio J. Fuentes-Delgado,Antonio Ugalde,Núria Homedes
Journal of Empirical Research on Human Research Ethics.2017;12(4)232
[DOI]
25Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor
Maria Elena Flacco,Lamberto Manzoli,Stefania Boccia,Lorenzo Capasso,Katina Aleksovska,Annalisa Rosso,Giacomo Scaioli,Corrado De Vito,Roberta Siliquini,Paolo Villari,John P.A. Ioannidis
Journal of Clinical Epidemiology.2015;68(7)811
[DOI]
26In Situ Simulation to Mitigate Threats to Participation in a Multicenter Clinical Trial in High-Acuity, Low-Frequency Setting
Steven Chan,Lynn Babcock,Gary Geis,Mary Frey,Venita Robinson,Benjamin Kerrey
Simulation in Healthcare: The Journal of the Society for Simulation in Healthcare.2019;14(1)1
[DOI]
27In Situ Simulation to Mitigate Threats to Participation in a Multicenter Clinical Trial in High-Acuity, Low-Frequency Setting
Gregory J. Hather
Simulation in Healthcare: The Journal of the Society for Simulation in Healthcare.2016;14(1)191
[DOI]
  Feedback 
  Subscribe 

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal